Serveur d'exploration sur le lymphœdème - Curation (Ncbi)

Index « Keywords » - entrée « Ivermectin (adverse effects) »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Ivermectin (administration & dosage) < Ivermectin (adverse effects) < Ivermectin (blood)  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 37.
[0-20] [0 - 20][0 - 37][20-36][20-40]
Ident.Authors (with country if any)Title
000377 (????) S K Dunyo [Ghana] ; F K Nkrumah ; P E SimonsenA randomized double-blind placebo-controlled field trial of ivermectin and albendazole alone and in combination for the treatment of lymphatic filariasis in Ghana.
000B46 (2002) Philip J. Cooper [États-Unis] ; Lawrence B. Schwartz ; Anne-Marie Irani ; Kwablah Awadzi ; Ronald H. Guderian ; Thomas B. NutmanAssociation of transient dermal mastocytosis and elevated plasma tryptase levels with development of adverse reactions after treatment of onchocerciasis with ivermectin.
000B76 (2002) Moses J. Bockarie [Papouasie-Nouvelle-Guinée] ; Daniel J. Tisch ; Will Kastens ; Neal D E. Alexander ; Zachary Dimber ; Florence Bockarie ; Ervin Ibam ; Michael P. Alpers ; James W. KazuraMass treatment to eliminate filariasis in Papua New Guinea.
000E59 (1992) J L Cartel [Polynésie française] ; J P Moulia-Pelat ; P. Glaziou ; L N Nguyen ; S. Chanteau ; J F RouxResults of a safety trial on single-dose treatments with 400 mcg/kg of ivermectin in bancroftian filariasis.
000F23 (1992) H J Zheng [République populaire de Chine] ; W F Piessens ; Z H Tao ; W F Cheng ; S H Wang ; S Z Cheng ; Y M Ye ; L F Luo ; X R Chen ; G B Gan[Efficacy of ivermectin for control of microfilaremia recurring after treatment with diethylcarbamazine. I. Clinical and parasitological observations].
001708 (2003) Report on active surveillance for adverse events following the use of drug co-administrations in the global programme to eliminate lymphatic filariasis.
001819 (????) J L Cartel [Polynésie française] ; N L Nguyen ; J P Moulia-Pelat ; R. Plichart ; P M Martin ; A. SpiegelMass chemoprophylaxis of lymphatic filariasis with a single dose of ivermectin in a Polynesian community with a high Wuchereria bancrofti infection rate.
001845 (1992) J L Cartel [Polynésie française] ; A. Spiegel ; L. Nguyen ; J P Moulia-Pelat ; P M Martin ; J F Roux[Comparative efficacy of annual and semi-annual doses of ivermectin or diethylcarbamazine for the prevention of lymphatic filariasis].
001E00 (2005) P. Vanamail [Inde] ; K D Ramaiah ; S. Subramanian ; S P Pani ; J. Yuvaraj ; P K DasPattern of community compliance with spaced, single-dose, mass administrations of diethylcarbamazine or ivermectin, for the elimination of lymphatic filariasis from rural areas of southern India.
002138 (2004) S P Pani ; G Subramanyam Reddy ; P. Vanamail ; N. Venkatesvarlou ; L K Das ; A P VijayanTolerability and efficacy of single dose diethylcarbamazine (DEC) alone or co-administration with Ivermectin in the clearance of Wuchereria bancrofti microfilaraemia in Pondicherry, South India.
002885 (????) M. Sabry [Égypte] ; H. Gamal ; N. El-Masry ; M E KilpatrickA placebo-controlled double-blind trial for the treatment of bancroftian filariasis with ivermectin or diethylcarbamazine.
002C48 (2008) Lymphatic filariasis.
002F33 (1991) H J Zheng [République populaire de Chine] ; W F Piessens ; Z H Tao ; W F Cheng ; S H Wang ; S H Cheng ; Y M Ye ; L F Luo ; X R Chen ; G B GanEfficacy of ivermectin for control of microfilaremia recurring after treatment with diethylcarbamazine. I. Clinical and parasitologic observations.
002F92 (????) D G Addiss [États-Unis] ; M L Eberhard ; P J Lammie ; W L Hitch ; H C SpencerTolerance of single high-dose ivermectin for treatment of lymphatic filariasis.
003687 (2009) J. Horton [Royaume-Uni]The development of albendazole for lymphatic filariasis.
003B56 (1991) J L Cartel [Polynésie française] ; A. Spiegel ; L. Nguyen ; B. Genelle ; J F RouxDouble blind study on efficacy and safety of single doses of ivermectin and diethylcarbamazine for treatment of Polynesian Wuchereria bancrofti carriers. Results at six months.
004452 (2011) Francis Anto [Ghana] ; Victor Asoala ; Thomas Anyorigiya ; Abraham Oduro ; Martin Adjuik ; Patricia Akweongo ; Raymond Aborigo ; Langbong Bimi ; Joseph Amankwa ; Abraham HodgsonSimultaneous administration of praziquantel, ivermectin and albendazole, in a community in rural northern Ghana endemic for schistosomiasis, onchocerciasis and lymphatic filariasis.
004493 (2011) A. Hoerauf [Allemagne] ; K. Pfarr ; S. Mand ; A Y Debrah ; S. SpechtFilariasis in Africa--treatment challenges and prospects.
004580 (1990) E A Ottesen ; V. Vijayasekaran ; V. Kumaraswami ; S V Perumal Pillai ; A. Sadanandam ; S. Frederick ; R. Prabhakar ; S P TripathyA controlled trial of ivermectin and diethylcarbamazine in lymphatic filariasis.
004600 (2011) Meeting of the International Task Force for Disease Eradication, April 2011.
005912 (2013) Yaya Ibrahim Coulibaly [Mali] ; Ilo Dicko [Mali] ; Modibo Keita [Mali] ; Mahamadou Minamba Keita [Mali] ; Moussa Doumbia [Mali] ; Adama Daou [Mali] ; Fadima Cheick Haidara [Mali] ; Moussa Hama Sankare [Mali] ; John Horton [Royaume-Uni] ; Caroline Whately-Smith [Royaume-Uni] ; Samba Ousmane Sow [Mali]A Cluster Randomized Study of The Safety of Integrated Treatment of Trachoma and Lymphatic Filariasis in Children and Adults in Sikasso, Mali

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Ncbi/Curation
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i -k "Ivermectin (adverse effects)" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i  \
                -Sk "Ivermectin (adverse effects)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    Ncbi
   |étape=   Curation
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Ivermectin (adverse effects)
}}

Wicri

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024